홈 › 유방암 › 버지니아

버지니아의 유방암 임상 시험

유방암 관련 연구 84개가 버지니아 내 여러 지역에서 참여자를 모집하고 있습니다.

버지니아의 도시

공식 연구 텍스트(영어)

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

Virginia Oncology Associates (VOA) ( Site 8001), Norfolk

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06797635

A Study to Learn How Well Participants With a Specific Type of Early Breast Cancer (ER-Positive, HER2-Negative) Tolerate and Stay on Treatment With Giredestrant and How They Feel During Treatment

Virginia Cancer Institute, Richmond

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07827573

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Augusta Health Center for Cancer and Blood Disorders, Fishersville

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03418961

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

Research Facility, Norfolk

피험자 모집 중1/2상

전 연령 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06590857

A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer

NEXT Virginia, Fairfax

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07905001

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Bon Secours Cancer Institute at St. Francis ( Site 0048), Midlothian
Virginia Oncology Associates (VOA) ( Site 8008), Norfolk
Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 8005), Roanoke

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06966700

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Virginia Cancer Specialists, Fairfax

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07007559

The Vanguard Study: Testing a New Way to Screen for Cancer

Sentara Martha Jefferson Hospital, Charlottesville
Inova Schar Cancer Institute, Fairfax
Inova Fair Oaks Hospital, Fairfax
외 5개

피험자 모집 중건강한 지원자 환영

45세 ~ 75세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06995898

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

NEXT Virginia, Fairfax

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07029399

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Inova Schar Cancer Institute, Fairfax
Virginia Cancer Specialists, PC, Fairfax

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06324357

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Inova, Fairfax

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07214532

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Next Oncology, Fairfax

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT05315700

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Virginia Cancer Specialists, PC, Fairfax
Virginia Oncology Associates, Norfolk

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06982521

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Virginia Cancer Specialists, Fairfax

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07174336

E-Mindfulness Approaches for Living After Breast Cancer

Inova Alexandria Hospital, Alexandria
Inova Schar Cancer Institute, Fairfax
Inova Fair Oaks Hospital, Fairfax
외 14개

피험자 모집 중3상

18세 ~ 50세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06748222

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

University of Virginia Health System, Charlottesville
Inova Schar Cancer Institute, Fairfax

피험자 모집 중2상

18세 이상 · 여성 · 2026. 11. 4. 업데이트됨 · NCT07287098

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Chesapeake Regional Medical Center, Chesapeake
Augusta Health Center for Cancer and Blood Disorders, Fishersville
Bon Secours Memorial Regional Medical Center, Mechanicsville
외 7개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

USOR Virginia Cancer Specialists, Fairfax
USOR Virginia Oncology Associates, Norfolk

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05579366

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Augusta Health Center for Cancer and Blood Disorders, Fishersville
Hematology Oncology Associates of Fredericksburg Inc, Fredericksburg
Centra Alan B Pearson Regional Cancer Center, Lynchburg
외 6개

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06418204

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

Inova Schar Cancer Institute, Falls Church

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06400472

Distance-Based Exercise to Preserve Function and Prevent Disability

Bon Secours Memorial Regional Medical Center, Mechanicsville
Bon Secours Saint Francis Medical Center, Midlothian
Bon Secours Saint Mary's Hospital, Richmond

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07059884

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Kaiser Permanente-Burke Medical Center, Burke
University of Virginia Cancer Center, Charlottesville
Augusta Health Center for Cancer and Blood Disorders, Fishersville
외 12개

피험자 모집 중3상

18세 ~ 60세 · 여성 · 2026. 11. 4. 업데이트됨 · NCT05879926

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Virginia Oncology Associates (VOA) ( Site 8001), Norfolk
Shenandoah Oncology ( Site 8004), Winchester

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07060807

A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer

Next Virginia, Fairfax

피험자 모집 중1상

18세 이상 · 여성 · 2026. 11. 3. 업데이트됨 · NCT07524855

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

NEXT Virginia, Fairfax

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07524322

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Bon Secours Cancer Institute at Memorial Regional, Mechanicsville
Bon Secours St. Francis Medical Center, Midlothian
Bon Secours Cancer Institute at St. Mary's, Richmond

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT07173751

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Inova Schar Cancer Institute, Falls Church

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06774963

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Virginia Cancer Specialists, Fairfax
Virginia Oncology Associates, Norfolk
Shenandoah Oncology, Winchester

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT07102381

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

NEXT Oncology, Fairfax

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07109726

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Alan B. Pearson Regional Cancer Center, Lynchburg
Bon Secours Cancer Institute at St. Francis, Midlothian
VCU Massey Comprehensive Cancer Center, Richmond

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06401421

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Virginia Oncology Associates (Norfolk) - USOR, Norfolk

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT07100106

Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

NEXT Oncology Virginia, Fairfax

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07807345

Single FrAction Interstitial BreaSt BracHytherApy

Virginia Commonwealth University, Richmond

피험자 모집 중2상

40세 ~ 85세 · 여성 · 2026. 10. 23. 업데이트됨 · NCT07654257

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

NEXT Virginia, Fairfax

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07383506

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

NEXT Virginia, Fairfax

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07287995

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Virginia Cancer Specialists-Fairfax, Fairfax

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07287917

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

Inova Schar Cancer Institute ( Site 0051), Fairfax

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT06686394

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

Research Site, Midlothian

피험자 모집 중3상

18세 ~ 130세 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07647328

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Virginia Cancer Specialists, PC, Arlington
Virginia Oncology Associates, Chesapeake
Virginia Cancer Specialists, Fairfax
외 8개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07062965

A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors

NEXT Virginia Cancer Center- Merrifield Tech Center, Fairfax

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT07767474

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.